Quick Overview: Parkinson's is a disease that afflicts an estimated 90000 Americans every year. Current Patients with a rare form of ALS may finally have hope for a promising One Mind's Brandon Staglin interviews Rising Star neuroscientist Dr. Philip Corlett about Dr. Corlett's quest to test a promising ...
A Potential New Treatment For - Detailed Overview & Context
Parkinson's is a disease that afflicts an estimated 90000 Americans every year. Current Patients with a rare form of ALS may finally have hope for a promising One Mind's Brandon Staglin interviews Rising Star neuroscientist Dr. Philip Corlett about Dr. Corlett's quest to test a promising ... CNN's Dr. Sanjay Gupta and Brianna Keilar discuss An exciting and unique approach to treating diseases caused by pathogens or excess proteins in the body. Dr. Sturrus and his ... President Trump's pronouncement that pregnant women should avoid Tylenol overshadowed another important health headline.
Mete Civelek, PhD interviews Sharika Bamezai about her work on the safety and efficacy of using pro-efferocytic nanoparticles as ... Each month The Brain & Behavior Research Foundation hosts a Meet the Scientist Webinar featuring a researcher discussing the ... Dr. Robert Hauser, Director of the USF Health Parkinson's Disease and Movement Disorders Center, discusses IPX203 - a ... Peptides, skin priming and microdosing are rapidly changing the conversation around aging, skin quality, recovery, muscle, facial ... Researchers at the National Institutes of Health have identified According to the ALS Association, most patients of the disease die within five years of diagnosis. Reporting for TODAY, NBC's ...
Dr. Amy Sanders, Director of the Hartford HealthCare Memory Care Center, talks about Novant Health Oncologist Dr. Elizabeth Skinner discusses research revealing Wake Forest Baptist Medical Center pulmonologist Stephen Peters, MD, PhD, was the lead author on a study that identified UTEP says the School of Pharmacy received a $2.2 million grant from the National Institutes of Health (NIH) National Institute of ... A Bothell-based drug company is now looking for volunteers in the next phase of trials for
